RFK Jr. Plans to Open Sale of 14 Peptide Drugs
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Robert F. Kennedy Jr. has claimed he will open up the sale of "about 14" injectable peptide drugs, a subset of 17 compounds the FDA restricted in 2023 citing "potential significant safety risks"
- None of the 17 restricted peptides have been proved safe or effective for human use, according to the article, undermining any case for reversing the FDA's 2023 decision
- Grey-market peptides are often bought from China "for research use only," and the number of retailers selling them in the UK and Europe suggests widespread off-label use already exists
- Silicon Valley is pioneering self-directed medical speculation with peptide therapies, betting risky, minimally evidenced treatments might deliver a physical or cognitive edge
- US-based pharmacies and the group behind the Enhanced Games sports contest are already lobbying to sell these peptides, meaning a regulatory opening would find a ready commercial pipeline
- The Make America Healthy Again (MAHA) framework replaces the precautionary principle with personal-choice rhetoric, treating large-scale public health interventions with suspicion while unleashing individual decisions like drinking unpasteurised milk
Why it matters: Kennedy's plan would effectively convert an unregulated grey market into the primary market for 14 injectable compounds, none of which have cleared human safety trials. US pharmacies and the Enhanced Games group are already lobbying to sell them, meaning the shift would move unproven substances from "research use only" into mass consumer circulation under MAHA's personal-choice framework. Other governments are unlikely to be as permissive.
